CTL scientists have had one of their articles published in a recent issue of MedLab magazine. In this article, they discuss new technology that enables high-throughput microbial detection. They al...
[more...]
CTL’s Reference Sample QC Sets™ offer outstanding inter-assay control. Use CTL's QC Sets™ not only for validation and protocol setup purposes, but also as internal controls for clinical trials...
Cellular Technology Ltd.'s founder, Dr. Paul V. Lehmann, together with a network of closely collaborating scholars and scientists, pride themselves in having elevated ELISPOT to an exact science in a series of peer-reviewed publications. This in-house expertise distinguishes CTL from all of its competitors and ensures that CTL will continue to drive new developments in the field.